This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Biophore India Pharmaceuticals Pvt. Ltd.. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2022
Title: Suresh Babu Namana: Innovator in Pharmaceutical Chemistry
Introduction
Suresh Babu Namana is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, holding three patents to his name. His work focuses on innovative methods for synthesizing important pharmaceutical compounds.
Latest Patents
One of his latest patents is titled "Method for the preparation of sulfobutylether beta cyclodextrin sodium." This invention relates to an improved method for synthesizing sulfobutylether beta cyclodextrin sodium, providing an amorphous form with a 1,4-butane sultone content of less than 0.5 ppm. Additionally, it ensures that the compound contains less than 35 IU/g of bacterial endotoxins. Another significant patent is "Process for the preparation of 4-[(1-hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl) oxy] benzonitrile (Crisaborole)." This invention describes a novel process for preparing substantially pure Crisaborole.
Career Highlights
Suresh Babu Namana is currently employed at Biophore India Pharmaceuticals Pvt. Ltd., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the quality and efficacy of pharmaceutical products.
Collaborations
He collaborates with talented professionals in his field, including Manik Reddy Pullagurla and Bhaskar Reddy Pitta. These collaborations have fostered a productive environment for innovation and development.
Conclusion
Suresh Babu Namana is a distinguished inventor whose contributions to pharmaceutical chemistry are noteworthy. His innovative patents and collaborative efforts continue to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile